Does once-daily etravirine have a role in the management of HIV-1 infection? - Wikidata - wikimedia - TriplyDB

Does once-daily etravirine have a role in the management of HIV-1 infection?

Does once-daily etravirine have a role in the management of HIV-1 infection?

http://www.wikidata.org/entity/Q38082671

about

Does once-daily etravirine have a role in the management of HIV-1 infection?

http://www.wikidata.org/entity/Q38082671

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Does once-daily etravirine have a role in the management of HIV-1 infection?

@en

type

label

Does once-daily etravirine have a role in the management of HIV-1 infection?

@en

prefLabel

Does once-daily etravirine have a role in the management of HIV-1 infection?

@en

P1433

Q38082671-9CE5BE59-5803-4379-A194-6C606CFB2521

P1476

Q38082671-CE35FBC7-EE19-4D39-89A0-6E26684D0306

P2093

Q38082671-EA259AC8-F462-4147-9933-3CF5EA87AB3A

P2860

Q38082671-11613AE9-F775-4D46-B8AF-391B38081E1E

Q38082671-46027B8F-3B5C-4AB0-9F13-076D68A2BDC3

Q38082671-4FC9044D-4368-4BB0-9D26-3A9B981E48C2

Q38082671-75F8BEE9-F956-45F6-9C0A-7AE27FDA425E

Q38082671-86DAA487-7BB1-46C2-811C-180A5B886CF9

Q38082671-95AF5074-D01D-49B8-81F1-B60511391C6E

Q38082671-A1AE1B6D-5F2D-437E-AA0A-51D9676FCAF9

Q38082671-BC3F96D1-746C-4826-99CB-6A05CB51F754

Q38082671-F36F6589-0ADA-43E8-864E-37E7C0475C33

P2888

Q38082671-CC715C2F-6C34-475F-8ECC-1C137B046CDE

P304

Q38082671-1FABB88F-EDC3-4744-8B59-81AEB900B59B

P31

Q38082671-48936C88-91A9-4476-AEFE-55D13F9B08AE

P356

Q38082671-09AC51DF-BFB7-42A8-8BD7-3CC3A3E7EC75

P433

Q38082671-ECCDD377-D17A-46C8-B2A8-A2C5433AF28B

P478

Q38082671-EC7C613D-8E10-4169-9158-7C68B6E1C536

P577

Q38082671-9C410CA6-C3FF-46B8-BE79-D00B9945AF9D

P6179

Q38082671-5792DA95-8912-404D-ACCA-409BDC9D4B65

P698

Q38082671-6B4A172C-FB9B-4F2C-90FD-22441F567106

P356

S40265-013-0022-6

P1433

P1476

Does once-daily etravirine have a role in the management of HIV-1 infection?

@en

P2093

Ian R McNicholl

http://www.w3.org/2001/XMLSchema#string

P2860

A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine.

Etravirine and rilpivirine: nonnucleoside reverse transcriptase inhibitors with activity against human immunodeficiency virus type 1 strains resistant to previous nonnucleoside agents.

TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1.

Pharmacokinetics of once-daily etravirine without and with once-daily darunavir/ritonavir in antiretroviral-naive HIV type-1-infected adults.

Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial.

Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE Trials.

Phase 2 double-blind, randomized trial of etravirine versus efavirenz in treatment-naive patients: 48-week results.

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial.

Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal function.

P2888

s40265-013-0022-6

P304

207-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-013-0022-6

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012397821

http://www.w3.org/2001/XMLSchema#string

P698

23420097

http://www.w3.org/2001/XMLSchema#string